Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

被引：0

作者：

Isabell D. Witzel

Karin Milde-Langosch

Ralph M. Wirtz

Claudia Roth

Maike Ihnen

Sven Mahner

Christine Zu Eulenburg

Fritz Jänicke

Volkmar Müller

机构：

[1] University Medical Center Hamburg-Eppendorf,Department of Gynecology

[2] Siemens Healthcare Diagnostics Products GmbH,Department of Medical Biometry and Epidemiology

[3] University Medical Center Hamburg-Eppendorf,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷

关键词：

Breast cancer; mRNA; uPA; PAI-1; HER2;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1709 / 1718

页数：9

共 13 条

[1] Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome
Witzel, Isabell D.
Milde-Langosch, Karin
Wirtz, Ralph M.
Roth, Claudia
Ihnen, Maike
Mahner, Sven
Eulenburg, Christine Zu
Jaenicke, Fritz
Mueller, Volkmar
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (11) : 1709 - 1718
[2] Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome
Bergqvist, J.
Ohd, J. F.
Smeds, J.
Klaar, S.
Isola, J.
Nordgren, H.
Elmberger, G. P.
Hellborg, H.
Bjohle, J.
Borg, A.-L.
Skoog, L.
Bergh, J.
ANNALS OF ONCOLOGY, 2007, 18 (05) : 845 - 850
[3] Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1
Ryan, BM
Konecny, GE
Kahlert, S
Wang, HJ
Untch, M
Meng, G
Pegram, MD
Podratz, KC
Crown, J
Slamon, DJ
Duffy, MJ
ANNALS OF ONCOLOGY, 2006, 17 (04) : 597 - 604
[4] Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1
Janz, M
Harbeck, N
Dettmar, P
Berger, U
Schmidt, A
Jürchott, K
Schmitt, M
Royer, HD
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 278 - 282
[5] Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients
Dovnik, Nina Fokter
Takac, Iztok
RADIOLOGY AND ONCOLOGY, 2017, 51 (01) : 65 - 73
[6] Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis
Choi, Y. H.
Ahn, J. H.
Kim, S. -B.
Jung, K. -H.
Gong, G. -Y.
Kim, M. -J.
Son, B. -H.
Ahn, S. -H.
Kim, W. K.
ANNALS OF ONCOLOGY, 2009, 20 (08) : 1337 - 1343
[7] Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast
Lin, Y.
Hatem, J.
Wang, J.
Quinn, A.
Hicks, D. G.
Tang, P.
BIOTECHNIC & HISTOCHEMISTRY, 2011, 86 (05) : 345 - 350
[8] HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
Lopes, Claudia
Piairo, Paulina
Chicharo, Alexandre
Abalde-Cela, Sara
Pires, Liliana R.
Corredeira, Patricia
Alves, Patricia
Muinelo-Romay, Laura
Costa, Luis
Dieguez, Lorena
CANCERS, 2021, 13 (17)
[9] Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: A tissue microarray immunophenotypic analysis on 98 patients
Florena, Ada Maria
Tripodo, Claudio
Guarnotta, Carla
Ingrao, Sabrina
Porcasi, Rossana
Martorana, Anna
Lo Bosco, Giosue
Cabibi, Daniela
Franco, Vito
PATHOBIOLOGY, 2007, 74 (06) : 317 - 322
[10] Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
Jevric, Marko
Matic, Ivana Z.
Krivokuca, Ana
Crnogorac, Marija Dordic
Besu, Irina
Damjanovic, Ana
Brankovic-Magic, Mirjana
Milovanovic, Zorka
Gavrilovic, Dusica
Susnjar, Snezana
Tepavcevic, Darija Kisic
Stanojkovic, Tatjana
BMC CANCER, 2019, 19 (1)

← 1 2 →